PTC Therapeutics | PTCT - Ordinary Share Capital


PTC Therapeutics reported $83.33M in Ordinary Share Capital for its fiscal quarter ending in June of 2026.





Ordinary Share Capital Change Date
Acadia Pharmaceuticals USD 172.31M 174K Sep/2026
Alnylam Pharmaceuticals USD 133.88M 141K Sep/2026
Amgen USD 541M 0 Sep/2026
BioCryst Pharmaceuticals USD 255.26M 42.2M Jun/2026
Biogen USD 146.7M 200K Sep/2025
BioMarin Pharmaceutical USD 193.68M 141K Sep/2026
Cytokinetics USD 138.76M 14.33M Jun/2026
Daiichi Sankyo JPY 1.82B 1.68M Sep/2026
Enanta Pharmaceuticals USD 212K 1000 Dec/2023
Gilead Sciences USD 1.24B 1000K Jun/2026
Incyte USD 200.98M 1.03M Jun/2026
Ionis Pharmaceuticals USD 166.41M 773K Sep/2026
Ironwood Pharmaceuticals USD 160K 0 Dec/2024
Karyopharm Therapeutics USD 22.54M 4.23M Mar/2026
Novartis USD 1.89B 12.09M Sep/2026
Pfizer USD 5.7B 1000K Sep/2026
PTC Therapeutics USD 83.33M 445K Jun/2026
Puma Biotechnology USD 5K 0 Jun/2024
Roche Holding CHF 796.77M 1.15M Jun/2026
Sarepta Therapeutics USD 107.23M 1.61M Sep/2026
TG Therapeutics USD 151.16M 1.92M Sep/2026
Ultragenyx Pharmaceutical USD 98.6M 300K Jun/2026
Vertex Pharmaceuticals USD 253.5M 200K Sep/2026
Xencor USD 74.33M 265K Jun/2026